GH Research PLC (GHRS)
NASDAQ·Healthcare·Biotechnology
$28.15
+0.68%
Mkt Cap $1.96B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (13 analysts)
$41.50
Range $32.00 – $65.00
Implied Upside
+47.4%
Consensus $41.50 vs current $28.15
NASDAQ·Healthcare·Biotechnology
$28.15
+0.68%
Mkt Cap $1.96B
Buy
4
Hold
0
Sell
0
Price Target (13 analysts)
$41.50
Range $32.00 – $65.00
+47.4%
Consensus $41.50 vs current $28.15